An NCI-designated Comprehensive Cancer Center
Jerry Cheng

Jerry Cheng, M.D.

Staff Physician, Department, Hematology & Hematopoietic Cell Transplantation
Clinical Expertise
  • Bone marrow transplantation
  • Pediatric hematology/oncology
Jerry Cheng, M.D. is a pediatric hematologist-oncologist who specializes in pediatric bone marrow transplants. He is also a member of the City of Hope/Kaiser Bone Marrow Transplantation Team. As a blood and cancer specialist for children, he says he has the privilege of getting to work with patients and their families.

Cheng works with a team of oncologists, pharmacists, nurse coordinators, pediatric nurses, social workers and medical assistants to provide the best care possible. He says that good communication is essential to their success. Cheng believes in treating the whole patient, not just the disease, and says that to him, mind, body and spirit are one.

Cheng went to medical school at University of California, Irvine and completed his pediatric residency and internship at UCLA Medical Center. His fellowship in pediatric hematology/oncology was also completed at the same institution.

Born and raised in Oahu, Hawaii, Cheng left the island life behind him after high school, though he still returns annually to enjoy the nice weather and kind people. When he’s not at work, he enjoys spending time with his family, exercising and playing golf.
  • Breckler, J., Cheng, J., Au, K., and Burnside, B.  “Novel Myosin VI Isoforms Are Abundantly Expressed in Retina.” Experimental Eye Research Jan. 2000 (70): 121-134.
  • Mora-Garcia, P., Cheng, J., Crans-Vargas, HN., Countouriotis, A., and Sakamoto, K. Transcriptional Regulators and Myelopoiesis: The Role of SRF and CREB as Targets of Cytokine Signaling. Stem Cells. 2003; 21:123-130.
  • Cheng, J. Tick Paralysis Case Report. Peds in Review 8/03.
  • Kanegaye, J., Cheng, J., McCaslin, I., Trocinski, D., and Silva, T. Improved Documentation of Wound Care With a Structured Encounter Form in the Pediatric Emergency Department. Ambulatory Pediatrics July-August 2005; 5(4): 253- 257.
  • Cheng, J., Moore, T.B., and Sakamoto, K., RNA Interference and Human Disease. Molecular Genetics and Metabolism, 2003 Sep-Oct;80(1-2): 121-8.
  • Shankar, D.B., Cheng, J., Wang, J., Pan, R., Countouriotis, A., Federman, N., Gill, A., Rao, N.P., Moore, T., and Sakamoto, K.M. “The role of CREB as a proto-oncogene in hematopoiesis and in acute myeloid leukemia.” Cancer Cell, 7:351-362, 2005.
  • Cheng, J., Esparza, S., Sakamoto, K., and Moore, T.B. Severe Lactic Acidosis in a Fourteen Year-old Female with Metastatic  Undifferentiated Carcinoma of Unknown Primary. Journal of Pediatric Hematology-Oncology, October 2004.
  • Cheng, J. and Sakamoto, K. “The Emerging Role of RNA Interference in the Design of Novel Therapeutics in Oncology.” October, Cell Cycle, 2004.
  • Cheng, J., and Sakamoto, K.M. “Management of Pediatric Acute Myeloid Leukemia” Medscape General Medicine: Topics in Pediatric Leukemia (
  • Shankar, D., Cheng, J.C., and Sakamoto, K.M. The Role of Cyclic AMP Response Element Binding Protein in Human Leukemias. Invited Review, Cancer, Sep 29, 2005.
  • Cheng, J.C., Sakamoto, K.M., Horwitz, E.M., Karsten, S.L., Shoemaker, L., Kornblum, H.I., and Malik, P.  “A Meeting Report: “New Technologies in Stem Cell Research.” Stem Cells  Jan 25, 2007.
  • Cheng, J.C., Esparza, S.E., and Sakamoto, K.M. “Potential role of CREB as a prognostic marker in acute myeloid leukemia.” Future Oncology, Aug. 2007;3(4):475-80.
  • Cheng, J.C., Kinjo, K., Wu, Winston., et al., “CREB is a critical regulator of normal hematopoiesis and leukemogenesis.” Blood, Feb. 1 2008; 111(3):1182-92.
  • Pellegrini, M., Cheng, J.C., Sakamoto, K.M., et al., “Expression Profile of CREB knockdown in Myeloid Leukemia Cells.” BMC Cancer,  2008, 8:264.
  • Solis O.E., Mehta R.I., Lai A, Mehta R.I., Farchoukh L.O., Green R.M., Cheng J.C., Natarajan S, Vinters H.V., Cloughesy T, and Yong W.H. “Rosette-forming glioneuronal tumor: a pineal region case with IDH1 and IDH2 mutation analyses and literature review of 43 cases.” J NeuroOncology, Sep 25, 2010.
  • Tidwell,T., Weschler, J., Ramesh, C., Trump, L., Salipante, S., Cheng, J.C., et al. Neutropenia-associated ELANE mutations disrupting translation initiation produce novel neutrophil elastase isoforms. Blood. November 1, 2013.
  • Epstein, Joel B, Raber-Durlacher, JE, Huysmans, MC, Schoordijk, M., Cheng, J.C., Bensadoun RJ, and Arany, P. Photobiomodulation therapy alleviates tissue fibroses associated with graft-versus-host disease: literature review and case reports. Photomedicine and Laser Surgery. Submitted March 2017.
In The News